SMI
12.207,57
PKT
-115,83
PKT
-0,94
%
Werbung
Analysen zu SMI-Werten
Datum | Rating | Analyst | |
---|---|---|---|
30.10.12 | Swiss Re buy | Vontobel Research | |
30.10.12 | ABB (Asea Brown Boveri) equal-weight | Morgan Stanley | |
30.10.12 | UBS outperform | RBC Capital Markets | |
30.10.12 | ABB (Asea Brown Boveri) buy | Vontobel Research | |
30.10.12 | UBS buy | Vontobel Research | |
30.10.12 | Geberit hold | Vontobel Research | |
30.10.12 | UBS halten | Independent Research GmbH | |
29.10.12 | Holcim hold | Deutsche Bank AG | |
29.10.12 | Holcim hold | Deutsche Bank AG | |
29.10.12 | Nestlé kaufen | Hamburger Sparkasse AG (Haspa) | |
29.10.12 | Novartis halten | Independent Research GmbH | |
29.10.12 | UBS overweight | J.P. Morgan Cazenove | |
29.10.12 | Sonova buy | Vontobel Research | |
29.10.12 | UBS hold | Société Générale Group S.A. (SG) | |
29.10.12 | Swiss Re buy | Vontobel Research | |
29.10.12 | UBS neutral | UBS AG | |
29.10.12 | UBS hold | Vontobel Research | |
29.10.12 | UBS neutral | Sarasin Research | |
29.10.12 | ABB (Asea Brown Boveri) halten | Independent Research GmbH | |
29.10.12 | Novartis outperform | Credit Suisse Group | |
26.10.12 | ABB (Asea Brown Boveri) hold | Société Générale Group S.A. (SG) | |
26.10.12 | ABB (Asea Brown Boveri) outperform | Exane-BNP Paribas SA | |
26.10.12 | Novartis outperform | Exane-BNP Paribas SA | |
26.10.12 | Novartis buy | Société Générale Group S.A. (SG) | |
26.10.12 | Logitech outperform | Exane-BNP Paribas SA | |
26.10.12 | Logitech neutral | UBS AG | |
26.10.12 | UBS neutral | Nomura | |
26.10.12 | UBS hold | Société Générale Group S.A. (SG) | |
26.10.12 | UBS neutral | Exane-BNP Paribas SA | |
26.10.12 | UBS equal-weight | Morgan Stanley | |
26.10.12 | Logitech hold | Vontobel Research | |
26.10.12 | Novartis reduce | Vontobel Research | |
26.10.12 | UBS neutral | Sarasin Research | |
25.10.12 | Novartis buy | Sarasin Research | |
25.10.12 | UBS hold | Vontobel Research | |
25.10.12 | Logitech neutral | Sarasin Research | |
25.10.12 | UBS neutral | Sarasin Research | |
25.10.12 | ABB (Asea Brown Boveri) neutral | Sarasin Research | |
25.10.12 | ABB (Asea Brown Boveri) buy | Vontobel Research | |
25.10.12 | Novartis reduce | Vontobel Research |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.